Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices

Heart Rhythm

Volumn 9, Issue 3, 2012, Pages 361-367

  Cano, Oscar ^a,b   Muñoz, Begoña ^a   Tejada, David ^a   Osca, Joaquín ^a   Sancho Tello, María José ^a   Olagüe, José ^a   Castro, José E ^a   Salvador, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

Author keywords

Cardiac arrhythmia devices; Heparin bridging; Oral anticoagulation

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; COST CONTROL; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEMATOMA; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; STROKE;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CARDIAC PACING, ARTIFICIAL; CLINICAL PROTOCOLS; COST SAVINGS; DEFIBRILLATORS, IMPLANTABLE; DRUG SUBSTITUTION; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; THROMBOEMBOLISM;

EID: 84857652113     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.10.010     Document Type: Article

References (21)

1. G. Michaud, F. Pelosi, M.D. Noble, B.P. Knight, F. Morady, S.A. Strickberger A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation J Am Coll Cardiol 35 2000 1915 1918 (Pubitemid 30342875)
2. U.K. Wiegand, D. LeJeune, F. Boguschewski Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy and perioperative antiplatelet/anticoagulation therapy Chest 126 2004 1177 1186 (Pubitemid 39391248)
3. C. Marquie, G. De Geeter, D. Klug Post-operative use of heparin increases morbidity of pacemaker implantation Europace 8 2006 283 287 (Pubitemid 43905736)
4. V. Pengo, U. Cucchini, G. Denas Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA) Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study Circulation 119 2009 2920 2927
5. M. Robinson, J.S. Healey, J. Eikelboom Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators Pacing Clin Electrophysiol 32 2009 378 382
6. J. De Bono, S. Nazir, N. Ruparelia, Y. Bashir, T. Betts, K. Rajappan Perioperative management of anticoagulation during device implantationthe UK perspective Pacing Clin Electrophysiol 33 2010 389 393
7. C. Tompkins, A. Cheng, D. Dalal Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation J Am Coll Cardiol 55 2010 2376 2382
8. D.J. Goldstein, W. Losquadro, H.M. Spotnitz Outpatient pacemaker procedures in orally anticoagulated patients Pacing Clin Electrophysiol 21 1998 1730 1734 (Pubitemid 28415469)
9. M.C. Giudici, D.L. Paul, P. Bontu, S.S. Barold Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy Pacing Clin Electrophysiol 27 2004 358 360 (Pubitemid 38352516)
10. A.S. Al-Khadra Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients Pacing Clin Electrophysiol 26 2003 511 514 (Pubitemid 36399207)
11. J.M. Tolosana, P. Berne, L. Mont Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial Eur Heart J 30 2009 1880 1884
12. A. Tischenko, L.J. Gula, R. Yee, G.J. Klein, A.C. Skanes, A.D. Krahn Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin Am Heart J 158 2009 252 256
13. H. Ghanbari, D. Feldman, M. Schmidt Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios Pacing Clin Electrophysiol 33 2010 400 406
14. I. Ahmed, E. Gertner, W.B. Nelson Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 2010 745 749
15. A. Cheng, S. Nazarian, J.A. Brinker Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial Heart Rhythm 8 2011 536 540
16. A.D. Krahn, J.S. Healey, C.S. Simpson, V. Essebag, S. Sivakumaran, D.H. Birnie Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada Heart Rhythm 6 2009 1276 1279
17. O. Cano, J. Osca, M.J. Sancho-Tello, J. Olagüe, J.E. Castro, A. Salvador Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices Europace 13 2011 395 401
18. R.O. Bonow, B.A. Carabello, C. Kanu ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 2006 e84 e231
19. V. Fuster, L.E. Rydn, D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 48 2006 854 906 (Pubitemid 44175743)
20. D.A. Garcia, S. Regan, L.E. Henault Risk of thromboembolism with short-term interruption of warfarin therapy Arch Intern Med 168 2008 63 69
21. D.A. Hirschl, V.R. Jain, H. Spindola-Franco, J.N. Gross, L.B. Haramati Prevalence and characterization of asymptomatic pacemaker and ICD lead perforation on CT Pacing Clin Electrophysiol 30 2007 28 32 (Pubitemid 46114925)